Beta Bionics, Inc. (BBNX) Enterprise Value (2023 - 2026)

Beta Bionics (BBNX) has 4 years of Enterprise Value data on file, last reported at -$30.3 million in Q1 2026.

• Quarterly Enterprise Value rose 86.91% year-over-year to -$30.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$30.3 million (up 86.91% YoY) and the FY2025 annual result came in at -$219.1 million, down 111.56% from the prior year.
• Enterprise Value advanced to -$30.3 million in Q1 2026 per BBNX's latest filing, from -$219.1 million in the prior quarter.
• The five-year high for Enterprise Value was -$13.0 million in Q2 2024, with the low at -$249.7 million in Q2 2025.
• Average Enterprise Value over 4 years is -$121.2 million, with a median of -$100.2 million recorded in 2023.
• Year-over-year, Enterprise Value plunged 1816.65% in 2025 and jumped 86.91% in 2026.
• Beta Bionics' Enterprise Value stood at -$96.7 million in 2023, then dropped by 7.06% to -$103.6 million in 2024, then sank by 111.56% to -$219.1 million in 2025, then jumped by 86.17% to -$30.3 million in 2026.
• Business Quant data shows BBNX's Enterprise Value at -$30.3 million in Q1 2026, -$219.1 million in Q4 2025, and -$228.7 million in Q3 2025.